Gastroenterology

A retrospective study found higher rates of gastrointestinal lesions and malignancy in patients with iron deficiency anaemia but confirmed that the absence of anaemia did not exclude serious gastrointestinal disease.

Around 700 people received free liver health checks during UEG Week 2026 in Barcelona through the Love Your Liver initiative, highlighting the role of accessible screening, early detection and public health awareness in tackling liver disease.

A large citizen science study evaluated the Blue Muffin test as a potential gut transit time biomarker, identifying associations with bowel habits, age, sex, and body mass index.

A microbiome-based classifier identified patients with newly diagnosed ulcerative colitis at risk of an aggressive disease course, achieving an AUC of 0.85 in distinguishing aggressive from indolent disease.

Red blood cell DNA profiling showed promise as a non-invasive approach to gastric cancer detection, achieving 82–89% sensitivity for Stage I disease across three multicentre validation cohorts.

A 17-protein blood-based biomarker signature showed promise for detecting early-stage colorectal cancer and advanced adenomas, supporting further investigation as a minimally invasive screening approach.

Chronic pancreatitis AI responses were generally accurate and safe, but DeepSeek-V3 scored lower for comprehensiveness than ChatGPT-4o and online platforms.

Upper gastrointestinal involvement in Crohn’s disease was not associated with reduced biologic treatment persistence, but it was linked to an increased risk of intestinal resection, particularly in patients with combined L4a and L4b involvement.